Biomea Fusion, Inc.
NASDAQ:BMEABiotechnology
-$0.03 today
- Market cap
- $53.18M
- Beta
- -0.33
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$0.62
Volume 3.50M
Average 1.52M
BMEA Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Biomea Fusion, Inc.NASDAQ: BMEA
Operating Expenses · Q1 FY2026 · quarter ended Mar 2026
Operating expenses declines year over year
Q1 FY2026 operating expenses of $12.73M fell 57.2% year over year, behind the -50.3% change in trailing-twelve-month operating expenses. Sequentially, it rose 9.0% from the prior quarter. Over 3 fiscal years it compounded at -1.5% a year.
Context
- Operating expenses increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -57.2% toward the trailing-twelve-month pace of -50.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 79.9M USD
- Year-over-year change
- -44.5%
- 4-year CAGR
- +17.7%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 79.9M | -44.5% |
| FY2024 | 2024-12-31 | 144.07M | +14.2% |
| FY2023 | 2023-12-31 | 126.14M | +50.8% |
| FY2022 | 2022-12-31 | 83.63M | +100.7% |
| FY2021 | 2021-12-31 | 41.67M | — |
Operating Expenses vs competitors
How BMEA compares with its peers on the latest reported figures
- BMEA's LTM Mar 2026 operating expenses of $65.98M is the 6th highest of the 9 companies compared; the peer median is $87.31M.
- Its year-over-year change of -50.3% is the 8th highest of 9, against a peer median of -4.7%.
- Over three fiscal years its annual growth of -1.5% compares with a peer median of +4.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $213.41M | -32.3% | +2.0% | 214.2% | |
| LTM Mar 2026 | $109.61M | +8.6% | -4.8% | — | |
| LTM Mar 2026 | $92.88M | -4.0% | +25.5% | — | |
| LTM Mar 2026 | $91.02M | -33.2% | -6.5% | — | |
| LTM Mar 2026 | $83.6M | -5.5% | +4.1% | — | |
| LTM Mar 2026 | $65.98M | -50.3% | -1.5% | — | |
CBUSCibus, Inc. | LTM Mar 2026 | $62.05M | -76.5% | +45.9% | 1447.8% |
| LTM Mar 2026 | $55.03M | +0.4% | — | 1398.8% | |
| LTM Mar 2026 | $29.76M | -3.7% | +15.1% | — | |
| Peer median (excluding BMEA) | $87.31M | -4.7% | +4.1% | 1398.8% | |
Competitors are the stored peer set for BMEA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 1.41M |
| Gross Profit | 0 | 0 | 0 | 0 | (1.41M) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 28M | 62.71M | 102.55M | 118.09M | 61.98M |
| Selling, General & Admin | 13.67M | 20.92M | 23.59M | 25.99M | 19.33M |
| Operating Expenses | 41.67M | 83.63M | 126.14M | 144.07M | 79.9M |
| Depreciation & Amortization | 249K | 691K | 1.52M | 1.75M | 1.41M |
| EBITDA | (41.32M) | (81.14M) | (115.74M) | (136.68M) | (60.39M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (41.67M) | (83.63M) | (126.14M) | (144.07M) | (81.31M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 100K | 1.81M | 8.88M | 5.64M | 1.86M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 100K | 1.81M | 8.88M | 5.64M | 19.51M |
| Income Before Tax | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| EPS (Diluted) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| Weighted Avg Shares | 23.86M | 29.27M | 34.11M | 36.11M | 52.23M |
| Weighted Avg Shares (Diluted) | 23.86M | 29.27M | 34.11M | 36.11M | 52.23M |
Biomea Fusion, Inc.
NASDAQ:BMEA
Intrinsic Alpha fair value
Locked
Current Price
$0.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.